There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...

FDA announced the launch of Elsa, a generative artificial intelligence (AI) tool designed to help employees from scientific ...

The FDA is moving quickly to bring artificial intelligence (AI) into the heart of its regulatory review process. On May 8, ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...